Loading product details…Cargando detalles del producto…Carregando detalhes do produto…

At a glance

AGORESEARCH
Specification
Category
Form
Knowledge source
Research focus
Reconstitution
Storage
COA

What is XA5?

ACTH-fragment analog profile for cognitive and neuroprotective research. The LPPEPTIDE knowledge record describes Semax as a synthetic heptapeptide related to ACTH 4-10, originally developed in Russia and reviewed for neuroprotective, cognitive, neurotrophic, cerebrovascular recovery, and optic-nerve support research. SEMAX 10mg is mapped to LPPeptide SKU XA10. Current storefront values use our product data: 10mg x 10 vials /box, $85.00 USD per box. LPPeptide reference specs: 5mg x 10 vials / 10mg x 10 vials.

Research context

The LPPEPTIDE knowledge record describes Semax as a synthetic heptapeptide related to ACTH 4-10, originally developed in Russia and reviewed for neuroprotective, cognitive, neurotrophic, cerebrovascular recovery, and optic-nerve support research. Research commonly reviews neurotrophic markers, cognition endpoints, stress-response context, and ACTH-fragment pathway literature.

Commonly matched with

XA5 is commonly reviewed alongside ML10, P41, WA3, BAC WATER, Selank. Keep each combination tied to a defined research objective and lot record.

Compliance notice

XA5 is supplied for research use only. It is not for human or veterinary use, not for consumption, and statements on this page are reference context rather than medical claims.

Research

Reference literature focus

The LPPEPTIDE knowledge record describes Semax as a synthetic heptapeptide related to ACTH 4-10, originally developed in Russia and reviewed for neuroprotective, cognitive, neurotrophic, cerebrovascular recovery, and optic-nerve support research. Research commonly reviews neurotrophic markers, cognition endpoints, stress-response context, and ACTH-fragment pathway literature.

Study design notes

Use the LPPeptide product knowledge record, current LPPeptide COA, and internal lab SOP to confirm identity, concentration, and endpoints before this material enters a study. The matched LPPeptide reference specification is 5mg x 10 vials / 10mg x 10 vials.

Dosing & Protocol

LPPeptide handling reference

LPPEPTIDE knowledge source: add 3.0 mL sterile water for about 1.67 mg/mL. Reference range is once daily 200-500 mcg. At this concentration, 1 U is about 16.7 mcg.

LPPEPTIDE preparation pattern: use sterile technique, add diluent slowly down the vial wall, avoid foaming, roll gently until dissolved, label the preparation date, refrigerate at 2-8 deg C, and protect from light.

Preparation

SEMAX 5mg ships as Lyophilized powder. Reconstitution note: LPPEPTIDE knowledge source: add 3.0 mL sterile water for about 1.67 mg/mL. Reference range is once daily 200-500 mcg. At this concentration, 1 U is about 16.7 mcg.. Record the final concentration and preparation date in the study log.

Storage

Lyophilized: -20 deg C, dry and dark. Reconstituted: 2-8 deg C; prepare aliquots when needed and avoid freeze-thaw.. Follow the most current lot-specific handling record whenever it is available.

Side Effects

Safety observations

Track neurologic, behavioral, and local tolerability observations. Human-use claims should not be inferred from research endpoints.

Contraindications

Do not use XA5 outside qualified research workflows. Review the current SDS, COA, and protocol exclusions before handling.

Interaction review

Review combinations with Selank, NAD+, MOTS-C, or other cognitive pathway materials.

COA & Testing

Certificate of Analysis

Each LPPeptide lot should be confirmed against current batch documentation before shipment or study use. This product page keeps XA10 visible so the SKU can be matched to the active COA.

Current catalog summary

  • SKU: XA5
  • Product: SEMAX 5mg
  • Storefront specification: 10mg x 10 vials /box
  • LPPeptide reference specs: 5mg x 10 vials / 10mg x 10 vials
  • Listed box price: $55.00 USD
  • Reference: LPPeptide product knowledge record

Testing checklist

  • Peptide identity or material identity
  • HPLC purity or assay result where applicable
  • Batch ID and test date
  • Sterility/endotoxin or accessory checks when applicable
  • Residual solvent and handling notes where applicable
About LPPEPTIDE

Direct catalog supply

LPPeptide product pages use our own SKU, package, price, and stock data first. LPPeptide knowledge mapping adds compound education, handling notes, and specification checks while lot-specific editorial content is being prepared.

Lot-specific content

For final release decisions, use the current product record, COA, handling sheet, and research SOP as the highest-priority source for this page.

What is XA5?

ACTH-fragment analog profile for cognitive and neuroprotective research. The LPPEPTIDE knowledge record describes Semax as a synthetic heptapeptide related to ACTH 4-10, originally developed in Russia and reviewed for neuroprotective, cognitive, neurotrophic, cerebrovascular recovery, and optic-nerve support research. SEMAX 10mg is mapped to LPPeptide SKU XA10. Current storefront values use our product data: 10mg x 10 vials /box, $85.00 USD per box. LPPeptide reference specs: 5mg x 10 vials / 10mg x 10 vials.

Research context

The LPPEPTIDE knowledge record describes Semax as a synthetic heptapeptide related to ACTH 4-10, originally developed in Russia and reviewed for neuroprotective, cognitive, neurotrophic, cerebrovascular recovery, and optic-nerve support research. Research commonly reviews neurotrophic markers, cognition endpoints, stress-response context, and ACTH-fragment pathway literature.

Commonly matched with

XA5 is commonly reviewed alongside ML10, P41, WA3, BAC WATER, Selank. Keep each combination tied to a defined research objective and lot record.

Compliance notice

XA5 is supplied for research use only. It is not for human or veterinary use, not for consumption, and statements on this page are reference context rather than medical claims.

Research

Reference literature focus

The LPPEPTIDE knowledge record describes Semax as a synthetic heptapeptide related to ACTH 4-10, originally developed in Russia and reviewed for neuroprotective, cognitive, neurotrophic, cerebrovascular recovery, and optic-nerve support research. Research commonly reviews neurotrophic markers, cognition endpoints, stress-response context, and ACTH-fragment pathway literature.

Study design notes

Use the LPPeptide product knowledge record, current LPPeptide COA, and internal lab SOP to confirm identity, concentration, and endpoints before this material enters a study. The matched LPPeptide reference specification is 5mg x 10 vials / 10mg x 10 vials.

Dosing & Protocol

LPPeptide handling reference

LPPEPTIDE knowledge source: add 3.0 mL sterile water for about 1.67 mg/mL. Reference range is once daily 200-500 mcg. At this concentration, 1 U is about 16.7 mcg.

LPPEPTIDE preparation pattern: use sterile technique, add diluent slowly down the vial wall, avoid foaming, roll gently until dissolved, label the preparation date, refrigerate at 2-8 deg C, and protect from light.

Preparation

SEMAX 5mg ships as Lyophilized powder. Reconstitution note: LPPEPTIDE knowledge source: add 3.0 mL sterile water for about 1.67 mg/mL. Reference range is once daily 200-500 mcg. At this concentration, 1 U is about 16.7 mcg.. Record the final concentration and preparation date in the study log.

Storage

Lyophilized: -20 deg C, dry and dark. Reconstituted: 2-8 deg C; prepare aliquots when needed and avoid freeze-thaw.. Follow the most current lot-specific handling record whenever it is available.

Side Effects

Safety observations

Track neurologic, behavioral, and local tolerability observations. Human-use claims should not be inferred from research endpoints.

Contraindications

Do not use XA5 outside qualified research workflows. Review the current SDS, COA, and protocol exclusions before handling.

Interaction review

Review combinations with Selank, NAD+, MOTS-C, or other cognitive pathway materials.

COA & Testing

Certificate of Analysis

Each LPPeptide lot should be confirmed against current batch documentation before shipment or study use. This product page keeps XA10 visible so the SKU can be matched to the active COA.

Current catalog summary

  • SKU: XA5
  • Product: SEMAX 5mg
  • Storefront specification: 10mg x 10 vials /box
  • LPPeptide reference specs: 5mg x 10 vials / 10mg x 10 vials
  • Listed box price: $55.00 USD
  • Reference: LPPeptide product knowledge record

Testing checklist

  • Peptide identity or material identity
  • HPLC purity or assay result where applicable
  • Batch ID and test date
  • Sterility/endotoxin or accessory checks when applicable
  • Residual solvent and handling notes where applicable
About LPPEPTIDE

Direct catalog supply

LPPeptide product pages use our own SKU, package, price, and stock data first. LPPeptide knowledge mapping adds compound education, handling notes, and specification checks while lot-specific editorial content is being prepared.

Lot-specific content

For final release decisions, use the current product record, COA, handling sheet, and research SOP as the highest-priority source for this page.

What is XA5?

ACTH-fragment analog profile for cognitive and neuroprotective research. The LPPEPTIDE knowledge record describes Semax as a synthetic heptapeptide related to ACTH 4-10, originally developed in Russia and reviewed for neuroprotective, cognitive, neurotrophic, cerebrovascular recovery, and optic-nerve support research. SEMAX 10mg is mapped to LPPeptide SKU XA10. Current storefront values use our product data: 10mg x 10 vials /box, $85.00 USD per box. LPPeptide reference specs: 5mg x 10 vials / 10mg x 10 vials.

Research context

The LPPEPTIDE knowledge record describes Semax as a synthetic heptapeptide related to ACTH 4-10, originally developed in Russia and reviewed for neuroprotective, cognitive, neurotrophic, cerebrovascular recovery, and optic-nerve support research. Research commonly reviews neurotrophic markers, cognition endpoints, stress-response context, and ACTH-fragment pathway literature.

Commonly matched with

XA5 is commonly reviewed alongside ML10, P41, WA3, BAC WATER, Selank. Keep each combination tied to a defined research objective and lot record.

Compliance notice

XA5 is supplied for research use only. It is not for human or veterinary use, not for consumption, and statements on this page are reference context rather than medical claims.

Research

Reference literature focus

The LPPEPTIDE knowledge record describes Semax as a synthetic heptapeptide related to ACTH 4-10, originally developed in Russia and reviewed for neuroprotective, cognitive, neurotrophic, cerebrovascular recovery, and optic-nerve support research. Research commonly reviews neurotrophic markers, cognition endpoints, stress-response context, and ACTH-fragment pathway literature.

Study design notes

Use the LPPeptide product knowledge record, current LPPeptide COA, and internal lab SOP to confirm identity, concentration, and endpoints before this material enters a study. The matched LPPeptide reference specification is 5mg x 10 vials / 10mg x 10 vials.

Dosing & Protocol

LPPeptide handling reference

LPPEPTIDE knowledge source: add 3.0 mL sterile water for about 1.67 mg/mL. Reference range is once daily 200-500 mcg. At this concentration, 1 U is about 16.7 mcg.

LPPEPTIDE preparation pattern: use sterile technique, add diluent slowly down the vial wall, avoid foaming, roll gently until dissolved, label the preparation date, refrigerate at 2-8 deg C, and protect from light.

Preparation

SEMAX 5mg ships as Lyophilized powder. Reconstitution note: LPPEPTIDE knowledge source: add 3.0 mL sterile water for about 1.67 mg/mL. Reference range is once daily 200-500 mcg. At this concentration, 1 U is about 16.7 mcg.. Record the final concentration and preparation date in the study log.

Storage

Lyophilized: -20 deg C, dry and dark. Reconstituted: 2-8 deg C; prepare aliquots when needed and avoid freeze-thaw.. Follow the most current lot-specific handling record whenever it is available.

Side Effects

Safety observations

Track neurologic, behavioral, and local tolerability observations. Human-use claims should not be inferred from research endpoints.

Contraindications

Do not use XA5 outside qualified research workflows. Review the current SDS, COA, and protocol exclusions before handling.

Interaction review

Review combinations with Selank, NAD+, MOTS-C, or other cognitive pathway materials.

COA & Testing

Certificate of Analysis

Each LPPeptide lot should be confirmed against current batch documentation before shipment or study use. This product page keeps XA10 visible so the SKU can be matched to the active COA.

Current catalog summary

  • SKU: XA5
  • Product: SEMAX 5mg
  • Storefront specification: 10mg x 10 vials /box
  • LPPeptide reference specs: 5mg x 10 vials / 10mg x 10 vials
  • Listed box price: $55.00 USD
  • Reference: LPPeptide product knowledge record

Testing checklist

  • Peptide identity or material identity
  • HPLC purity or assay result where applicable
  • Batch ID and test date
  • Sterility/endotoxin or accessory checks when applicable
  • Residual solvent and handling notes where applicable
About LPPEPTIDE

Direct catalog supply

LPPeptide product pages use our own SKU, package, price, and stock data first. LPPeptide knowledge mapping adds compound education, handling notes, and specification checks while lot-specific editorial content is being prepared.

Lot-specific content

For final release decisions, use the current product record, COA, handling sheet, and research SOP as the highest-priority source for this page.